People also searched for
HealthPRO Canada has posted a RFP for the following contract: SC07162 POINT OF CARE TESTING – DIABETES MANAGEMENT SUBMISSION CLOSING: Envelope 1 FRIDAY, MAY 31, 2024 at 12:00 PM ET Envelope 2 FRIDAY, MAY 31, 2024 at 12:00 PM ET Please go into Biddingo.com to view this Bid Notice and for any future addendums and/or amendments.
07162 Point of Care Testing – Diabetes Management 3sHealth RFPPOINTOFCARE Apr 18, 2024 02:00 PM CST May 31, 2024 10:00 AM CST Open
Point of Care Patient Testing Software Agency: State University of New York (SUNY) Category:Medical & Laboratory Equipment - Consulting & Other Services Issue Date:04/22/2024 Due Date: 05/13/2024 Ad Type:Discretionary procurements between $50,000 and $500,000
Reference:AB-2024-03029 SC07162 Point of Care Testing - Diabetes Management RFP Regional Health Authorities c/o HealthPRO Procurement Services Source:Government of Alberta APC - register with APC to receive updates, amendments & addenda NEW OR UPDATED April 18, 2024 05/31/2024 10:00:00 AM Alberta Time (Closing date appears to be Friday, May 31, 2024 - potential bidders should confirm) This opportunity is in the Prairies Region (includes the provinces
CONTRACTING OFFICER S REPRESENTATIVE (COR) Scheduling of work shall be arranged with at least one, or all the Point of Contacts below and in the following order: contract COR (Contracting Officers Representative) or contract ACOR (Alternate Contracting Officers Representative). See Table 1 below for Point of Contact information.
Detailed Description Ontario Health is seeking expressions of interest from laboratory medicine professionals for the position of Clinical Lead, Ontario Laboratory Medicine Program (OLMP) – Point of Care Testing. This is a unique opportunity to provide leadership to drive quality, accountability, and innovation in the laboratory medicine health system. This opportunity is open to all qualified candidates.
Specimen Testing 1. The Contractor shall provide the full range of clinical diagnostic testing capabilities to execute all required Alpa-1-anti-trypsin testing services as annotated in Attachment A.
